Biotech

Aeolus' AEOL 10150 Significantly Improves Survival in Animals Exposed to Mustard Gas

MISSION VIEJO, CA: ...

Portola Announces Oral Presentation of Phase 2 Data on PRT4445, Factor Xa Inhibitor Antidote, at 2013 International Society on Thrombosis and Haemostasis Congress

SOUTH SAN FRANCISCO, CA: ...

Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients

SAN FRANCISCO, CA and TOKYO: ...

MethylGene Shareholders Approve the Plan of Arrangement to Reincorporate in the United States as Mirati Therapeutics Inc.

MONTREAL, CANADA: ...

ProTrials Expands Management Team; Adds Connie Cyras as Director, Project Management

SUNNYVALE, CA and BOSTON, MA: ...

Prima BioMed to Move Forward With Phase 2 Clinical Program for CVac(TM) in Pancreatic, Colorectal, and Triple-Negative Breast Cancers

SYDNEY, AUSTRALIA: ...

Platine Pharma and Indicia Biotechnology Join Forces to Strengthen Leadership in Immuno-Assays

LYON, FRANCE: ...

Scientific Study Reveals ReadiDiesel(R) Meets Petroleum-Based Diesel Specifications Without Blending Fossil Fuels

VANCOUVER, BRITISH COLUMBIA: ReadiDiesel(R), made from energy feedstock from Calyx Bio-Ventures' subsidiary Agrisoma, stands out as petroleum alternative, made from non-food oilseed ...

Critical Outcome Technologies Inc. Completes Financing

LONDON, ONTARIO: ...

Genetic Technologies Settles Its Dispute With Ingelheim, Germany-Based Bioscientia Institute for Medical Diagnostics

MELBOURNE, AUSTRALIA: ...